403201

James Campbell, MD

Position
President and Chief Scientific Officer
Company
Centrexion Therapeutics Corporation
Bio
Dr. Campbell serves as President, co-founder, and Chief Scientific Officer of Centrexion Therapeutics, a Boston based company involved in the development of new therapeutics to treat chronic pain. He is Professor Emeritus of Neurosurgery at Johns Hopkins University. In the past, he has served as Vice Chairman and Director of the Residency Training in the Department of Neurosurgery at Hopkins, and presently serves as head of the Blaustein Pain Treatment Center Endowment for the Treatment of Pain, based at Johns Hopkins Hospital. He has served previously as Executive-in-Residence at the California based venture firm, InterWest Partners, and for several years also served as a consultant. Dr. Campbell was co-founder of Amplimmune (acquired by AstraZeneca for upfront payment of $250 million), a biotechnology company specializing in immuno-therapeutics. Dr. Campbell also co-founded CNS Therapeutics (acquired by Covidien for $100 million). He founded and served as CEO of Arcion Therapeutics, and Vallinex. He holds multiple patents in the life sciences. Dr. Campbell has a long record of accomplishment in academic medicine and neuroscience research. For much of his clinical career at Hopkins he was listed in Best Doctors in America. His work has been cited more than 14,000 times and his H-index is 60. Dr. Campbell has edited textbooks, published well over 100 peer-reviewed research papers, and served on the editorial board of several leading academic journals. He has received several national awards for research and public service, including the Jacob Javits Neuroscience Investigator Award from the National Institutes of Health; the Grass Award from the Society of Neurological Surgery; the Kerr Award for Research from the American Pain Society; and the Pain Research Award from Bristol Myers Squibb. He has also received awards for Public Service and Leadership from the American Pain Society and the American Pain Foundation. Dr. Campbell received his B.A. from the University of Michigan with High Honors and High Distinction and his M.D. degree from Yale University. He completed his residency in Neurosurgery at Johns Hopkins University and obtained post-doctoral training in Neurophysiology in the Department of Physiology at Johns Hopkins. Dr. Campbell is a Diplomate of the American Board of Neurological Surgery.
Interests
None yet.